362
Views
5
CrossRef citations to date
0
Altmetric
Review Article

Current and emerging EGFR therapies for glioblastoma

, , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ivana Jovčevska. (2018) Sequencing the next generation of glioblastomas. Critical Reviews in Clinical Laboratory Sciences 55:4, pages 264-282.
Read now

Articles from other publishers (4)

Ani-Simona Sevastre, Alexandra Costachi, Ligia Tataranu, Corina Brandusa, Stefan Artene, Olivian Stovicek, Oana Alexandru, Suzana Danoiu, Veronica Sfredel & Anica Dricu. (2021) Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review). Experimental and Therapeutic Medicine 22:6.
Crossref
Barbara Colella, Mayra Colardo, Gianna Iannone, Claudia Contadini, Cristina Saiz-Ladera, Claudia Fuoco, Daniela Barilà, Guillermo Velasco, Marco Segatto & Sabrina Di Bartolomeo. (2020) mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells. Cancers 12:8, pages 2266.
Crossref
Alja Zottel, Neja Šamec, Alja Videtič Paska & Ivana Jovčevska. (2020) Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs. Cancers 12:7, pages 1842.
Crossref
Ivana Jovčevska. (2020) Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma. Frontiers in Oncology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.